Literature DB >> 21611545

Original Papers: ON THE OCCURRENCE OF ABNORMAL DEPOSITS OF IRON IN THE BRAIN IN PARKINSONISM WITH SPECIAL REFERENCE TO ITS LOCALISATION.

J Lhermitte, W M Kraus, D McAlpine.   

Abstract

Entities:  

Year:  1924        PMID： 21611545      PMCID： PMC1068263          DOI： 10.1136/jnnp.s1-5.19.195

Source DB:  PubMed          Journal:  J Neurol Psychopathol        ISSN： 0266-8637


× No keyword cloud information.
  33 in total

Review 1.  The role of iron in neurodegeneration: prospects for pharmacotherapy of Parkinson's disease.

Authors:  K A Jellinger
Journal:  Drugs Aging       Date:  1999-02       Impact factor: 3.923

Review 2.  Considerations for measuring iron in post-mortem tissue of Parkinson's disease patients.

Authors:  Dominic J Hare; Manfred Gerlach; Peter Riederer
Journal:  J Neural Transm (Vienna)       Date:  2012-09-13       Impact factor: 3.575

3.  Subcellular compartmentalisation of copper, iron, manganese, and zinc in the Parkinson's disease brain.

Authors:  Sian Genoud; Blaine R Roberts; Adam P Gunn; Glenda M Halliday; Simon J G Lewis; Helen J Ball; Dominic J Hare; Kay L Double
Journal:  Metallomics       Date:  2017-10-18       Impact factor: 4.526

Review 4.  Is early-life iron exposure critical in neurodegeneration?

Authors:  Dominic J Hare; Manish Arora; Nicole L Jenkins; David I Finkelstein; Philip A Doble; Ashley I Bush
Journal:  Nat Rev Neurol       Date:  2015-06-23       Impact factor: 42.937

Review 5.  Mitochondrial iron metabolism and its role in neurodegeneration.

Authors:  Maxx P Horowitz; J Timothy Greenamyre
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

Review 6.  Alpha-synuclein and iron: two keys unlocking Parkinson's disease.

Authors:  Paul Lingor; Eleonora Carboni; Jan Christoph Koch
Journal:  J Neural Transm (Vienna)       Date:  2017-02-06       Impact factor: 3.575

Review 7.  Is NADH effective in the treatment of Parkinson's disease?

Authors:  R H Swerdlow
Journal:  Drugs Aging       Date:  1998-10       Impact factor: 3.923

Review 8.  Interactions of iron, dopamine and neuromelanin pathways in brain aging and Parkinson's disease.

Authors:  Fabio A Zucca; Juan Segura-Aguilar; Emanuele Ferrari; Patricia Muñoz; Irmgard Paris; David Sulzer; Tadeusz Sarna; Luigi Casella; Luigi Zecca
Journal:  Prog Neurobiol       Date:  2015-10-09       Impact factor: 11.685

Review 9.  Redox Mechanisms in Neurodegeneration: From Disease Outcomes to Therapeutic Opportunities.

Authors:  Juan I Sbodio; Solomon H Snyder; Bindu D Paul
Journal:  Antioxid Redox Signal       Date:  2018-05-04       Impact factor: 8.401

Review 10.  The history of the research of iron in parkinsonian substantia nigra.

Authors:  Andrzej Friedman; Jolanta Galazka-Friedman
Journal:  J Neural Transm (Vienna)       Date:  2012-09-02       Impact factor: 3.575
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.